US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 ...Middle East

PR Newswire - News
US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002
SHANGHAI, April 2, 2021 /PRNewswire/ -- On March 31, 2021, Jemincare group announced that their anti-SARS-CoV-2 neutralizing antibody, JMB2002, independently developed by Jemincare Shanghai Research Center, was approved by FDA for clinical trial in the United States. Preclinical data...

Hence then, the article about us fda approved jemincare to initiate clinical trial of neutralizing antibody jmb2002 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News